EGFR testing in lung cancer is ready for prime time.
作者： Fred R Hirsch , Paul A Bunn
DOI: 10.1016/S1470-2045(09)70110-X
关键词:
摘要:
elsevier.com
sci-hub.se 参考文章(9)
Ming-Sound Tsao, Akira Sakurada, Jean-Claude Cutz, Chang-Qi Zhu, Suzanne Kamel-Reid, Jeremy Squire, Ian Lorimer, Tong Zhang, Ni Liu, Manijeh Daneshmand, Paula Marrano, Gilda da Cunha Santos, Alain Lagarde, Frank Richardson, Lesley Seymour, Marlo Whitehead, Keyue Ding, Joseph Pater, Frances A. Shepherd, Erlotinib in lung cancer - molecular and clinical predictors of outcome. The New England Journal of Medicine. ,vol. 353, pp. 133- 144 ,(2005) , 10.1056/NEJMOA050736
Thomas J. Lynch, Daphne W. Bell, Raffaella Sordella, Sarada Gurubhagavatula, Ross A. Okimoto, Brian W. Brannigan, Patricia L. Harris, Sara M. Haserlat, Jeffrey G. Supko, Frank G. Haluska, David N. Louis, David C. Christiani, Jeff Settleman, Daniel A. Haber, Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib The New England Journal of Medicine. ,vol. 350, pp. 2129- 2139 ,(2004) , 10.1056/NEJMOA040938
Thomas J. Lynch, Taral Patel, Luke Dreisbach, Michael McCleod, William J. Heim, Hermann Robert, Paschold Eugene, Pautret Virginie, Martin R. Weber, Donald Woytowitz, B3-03: A randomized multicenter phase III study of cetuximab (Erbitux®) in combination with Taxane/Carboplatin versus Taxane/Carboplatin alone as first-line treatment for patients with advanced/metastatic Non-small cell lung cancer (NSCLC) Journal of Thoracic Oncology. ,vol. 2, pp. S340- S341 ,(2007) , 10.1097/01.JTO.0000283155.03863.E7
Lecia V. Sequist, Renato G. Martins, David Spigel, Steven M. Grunberg, Alexander Spira, Pasi A. Jänne, Victoria A. Joshi, David McCollum, Tracey L. Evans, Alona Muzikansky, Georgiana L. Kuhlmann, Moon Han, Jonathan S. Goldberg, Jeffrey Settleman, A. John Iafrate, Jeffrey A. Engelman, Daniel A. Haber, Bruce E. Johnson, Thomas J. Lynch, First-Line Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer Harboring SomaticEGFRMutations Journal of Clinical Oncology. ,vol. 26, pp. 2442- 2449 ,(2008) , 10.1200/JCO.2007.14.8494
Fred R. Hirsch, Roy S. Herbst, Christine Olsen, Kari Chansky, John Crowley, Karen Kelly, Wilbur A. Franklin, Paul A. Bunn, Marileila Varella-Garcia, David R. Gandara, Increased EGFR Gene Copy Number Detected by Fluorescent In Situ Hybridization Predicts Outcome in Non–Small-Cell Lung Cancer Patients Treated With Cetuximab and Chemotherapy Journal of Clinical Oncology. ,vol. 26, pp. 3351- 3357 ,(2008) , 10.1200/JCO.2007.14.0111
Fred R. Hirsch, Marileila Varella-Garcia, Paul A. Bunn, Wilbur A. Franklin, Rafal Dziadziuszko, Nick Thatcher, Alex Chang, Purvish Parikh, José Rodrigues Pereira, Tudor Ciuleanu, Joachim von Pawel, Claire Watkins, Angela Flannery, Gillian Ellison, Emma Donald, Lucy Knight, Dinah Parums, Nicholas Botwood, Brian Holloway, Molecular predictors of outcome with gefitinib in a phase III placebo-controlled study in advanced non-small-cell lung cancer Journal of Clinical Oncology. ,vol. 24, pp. 5034- 5042 ,(2006) , 10.1200/JCO.2006.06.3958
Fred R. Hirsch, Marileila Varella-Garcia, Paul A. Bunn, Michael V. Di Maria, Robert Veve, Roy M. Bremnes, Anna E. Barón, Chan Zeng, Wilbur A. Franklin, Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis. Journal of Clinical Oncology. ,vol. 21, pp. 3798- 3807 ,(2003) , 10.1200/JCO.2003.11.069
Shyamala Maheswaran, Lecia V. Sequist, Sunitha Nagrath, Lindsey Ulkus, Brian Brannigan, Chey V. Collura, Elizabeth Inserra, Sven Diederichs, A. John Iafrate, Daphne W. Bell, Subba Digumarthy, Alona Muzikansky, Daniel Irimia, Jeffrey Settleman, Ronald G. Tompkins, Thomas J. Lynch, Mehmet Toner, Daniel A. Haber, Detection of Mutations in EGFR in Circulating Lung-Cancer Cells The New England Journal of Medicine. ,vol. 359, pp. 366- 377 ,(2008) , 10.1056/NEJMOA0800668
R. Pirker, A. Szczesna, J. von Pawel, M. Krzakowski, R. Ramlau, K. Park, U. Gatzemeier, E. Bajeta, M. Emig, J. R. Pereira, FLEX: A randomized, multicenter, phase III study of cetuximab in combination with cisplatin/vinorelbine (CV) versus CV alone in the first-line treatment of patients with advanced non-small cell lung cancer (NSCLC) Journal of Clinical Oncology. ,vol. 26, pp. 3- 3 ,(2008) , 10.1200/JCO.2008.26.15_SUPPL.3